Locally Advanced or Metastatic Urothelial Carcinoma (UC)

DBCOND0123651Neoplasms Urogenital Diseases

Locally Advanced or Metastatic Urothelial Carcinoma (UC) is the indication for 4 drugs in DrugBank. It is covered by 6 curated, structured indications.

Also known as: Locally Advanced or Metastatic Urothelial Carcinoma
Classified under: Neoplasms
Urogenital Diseases
Urologic Neoplasms
Indicated drugs: Enfortumab vedotin
Erdafitinib
Pembrolizumab
Sacituzumab govitecan

What you can answer from here — as of October 22, 2026

4Indicated drugsWith each drug's targets and mechanism

Listed above

6Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

5Clinical trialsPhase, status and sponsor resolved per trial

4Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Locally Advanced or Metastatic Urothelial Carcinoma (UC) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account